Title: Results of the pilot study for the Hypertension in the Very Elderly Trial
Authors: Bulpitt, Christopher J ×
Beckett, Nigel S
Cooke, Jonathan
Dumitrascu, Dan L
Gil-Extremera, Blas
Nachev, Choudomir
Nunes, Maria
Peters, Ruth
Staessen, Jan A
Thijs, Lutgarde #
Issue Date: Dec-2003
Series Title: Journal of hypertension vol:21 issue:12 pages:2409-2417
Conference: 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting location:Prague, Czech Repubic date:23-27 June 2002
Abstract: BACKGROUND: The risks and benefits of treating hypertension in individuals older than 80 years are uncertain. A meta-analysis has suggested that a reduction in stroke events of 36% may have to be balanced against a 14% increase in total mortality. OBJECTIVES: To report the results of the pilot study of the Hypertension in the Very Elderly Trial (HYVET), which is in progress to address these issues. METHODS: The HYVET-Pilot was a multicentre international open pilot trial. In 10 European countries, 1283 patients older than 80 years and with a sustained blood pressure of 160-219/90-109 mmHg were allocated randomly to one of three treatments: a diuretic-based regimen (usually bendroflumethiazide; n = 426), an angiotensin-converting enzyme inhibitor regimen (usually lisinopril; n = 431) or no treatment (n = 426). The procedure permitted doses of the drug to be titrated and diltiazem slow-release to be added to active treatment. Target blood pressure was < 150/80 mmHg and mean follow-up was 13 months. RESULTS: In the combined actively treated groups, the reduction in stroke events relative hazard rate (RHR) was 0.47 [95% confidence interval (CI) 0.24 to 0.93] and the reduction in stroke mortality RHR was 0.57 (95% CI 0.25 to 1.32). However, the estimate of total mortality supported the possibility of excess deaths with active treatment (RHR 1.23, 95% CI 0.75 to 2.01). CONCLUSIONS: The preliminary results support the need for the continuing main HYVET trial. It is possible that treatment of 1000 patients for 1 year may reduce stroke events by 19 (nine non-fatal), but may be associated with 20 extra non-stroke deaths.
ISSN: 0263-6352
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Hypertension and Cardiovascular Epidemiology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
03-37-P.pdf Published 116KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science